News & Announcements

Study to Evaluate Immunogenicity

By Deanna SonniAugust 22, 2019December 4th, 2021No Comments

CLINICALTRIALS

Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals’ Candidate Malaria Vaccine (257049)

https://clinicaltrials.gov/ct2/show/results/NCT01345240?cond=malaria+vaccine&rank=5&view=results

Spread the love

Previous PostConcluso il progetto Finanziato fondi OPM Valdesi
Next PostDrug-resistant malaria is spreading across Asia

Leave a Reply

You must be logged in to post a comment.

English